Lupus Foundation of America18h
Lupus Research Highlights From American College of Rheumatology’s 2024 Scientific Meeting
The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...
pharmaphorum2d
GSK’s Benlysta claims first FDA okay for lupus kidney damage
GlaxoSmithKline’s Benlysta has been on the market for almost a decade, but it still has some tricks up its sleeve – it’s just become the first and only FDA-approved treatment for lupus ...
Medscape2d
Monoclonal Antibodies in Rheumatoid Arthritis
No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).
pharmaphorum4d
AZ's lupus drug Saphnelo cleared in EU, challenging GSK's Benlysta
It is notoriously hard to treat effectively. Saphnelo will compete in the market most closely with GlaxoSmithKline's BLyS inhibitor Benlysta (belimumab), which has been available in the EU to ...